Search results
Feb 27, 2024 · The Vaccine study confirmed that the Moderna and Pfizer/BioNTech vaccines are linked in rare cases to myocarditis and pericarditis, conditions involving inflammation of the heart muscle and...
Sep 9, 2022 · Pfizer and Moderna mRNA COVID-19 vaccines were associated with an excess risk of serious adverse events of special interest of 10.1 and 15.1 per 10,000 vaccinated over placebo baselines of 17.6 and 42.2 (95 % CI −0.4 to 20.6 and −3.6 to 33.8), respectively.
Feb 26, 2024 · The study, published in Vaccine, confirmed previously identified rare safety signals for myocarditis and pericarditis after a mRNA vaccine (Pfizer and Moderna) and Guillain-Barré syndrome and cerebral venous sinus thrombosis (CVST) after viral vector vaccines (AstraZeneca).1
Aug 25, 2021 · Figure 4 shows the absolute risk associated with vaccination, alongside the absolute risk associated with SARS-CoV-2 infection, for the same adverse events.
- Noam Barda, Noa Dagan, Yatir Ben-Shlomo, Eldad Kepten, Jacob Waxman, Reut Ohana, Miguel A Hernán, Ma...
- 2021
- Overview
- Reporting of Vaccine Adverse Events
- References
On September 21, 2021, this report was posted online as an MMWR Early Release.
Altmetric:
Citations:
Views:
Views equals page views plus PDF downloads
Tables
Providers are required to report adverse events (including administration errors, serious adverse events, cases of multisystem inflammatory syndrome, and cases of COVID-19 that result in hospitalization or death) that occur after receipt of any COVID-19 vaccine to VAERS (8). Information on how to submit a report to VAERS is available at https://vae...
1.Oliver SE, Gargano JW, Marin M, et al. The Advisory Committee on Immunization Practices’ interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine—United States, December 2020. MMWR Morb Mortal Wkly Rep 2020;69:1922–4. https://doi.org/10.15585/mmwr.mm6950e2external icon
2.Wallace M, Woodworth KR, Gargano JW, et al. The Advisory Committee on Immunization Practices’ interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine in adolescents aged 12–15 years—United States, May 2021. MMWR Morb Mortal Wkly Rep 2021;70:749–752. https://doi.org/10.15585/mmwr.mm7020e1external icon
3.Food and Drug Administration. Comirnaty. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2021. https://www.fda.gov/vaccines-blood-biologics/comirnatyexternal icon
4.Advisory Committee on Immunization Practices. ACIP meeting information. Atlanta, GA: US Department of Health and Human Services, CDC; 2021. https://www.cdc.gov/vaccines/acip/meetings/index.html
5.Polack FP, Thomas SJ, Kitchin N, et al.; C4591001 Clinical Trial Group. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 2020;383:2603–15. https://doi.org/10.1056/NEJMoa2034577external icon PMID:33301246external icon
6.Walsh EE, Frenck RW Jr, Falsey AR, et al. Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates. N Engl J Med 2020;383:2439–50. https://doi.org/10.1056/NEJMoa2027906external icon PMID:33053279external icon
- Kathleen Dooling, Julia W Gargano, Danielle Moulia, Megan Wallace, Hannah G Rosenblum, Amy E Blain, ...
- 2021
Yes. The two mRNA vaccines, Pfizer and Moderna, authorized by the U.S. Food and Drug Administration (FDA) and recommended by the Centers for Disease Control and Prevention (CDC), are very safe and very good at preventing serious or fatal cases of COVID-19. The risk of serious side effects associated with these vaccines is very small.
Dec 17, 2020 · Mostly mild and moderate side effects are the safety profiles of both the Moderna and Pfizer/BioNTech vaccines — and that’s why the FDA in the US and drug regulators in other countries around...
